Status:

WITHDRAWN

Renal Function in Adults With Congenital Heart Disease.

Lead Sponsor:

Royal Brompton & Harefield NHS Foundation Trust

Conditions:

Cardiovascular Abnormalities

Kidney Failure

Eligibility:

All Genders

18+ years

Brief Summary

Impaired kidney function is associated with a poor outcome in patients with heart failure but it is not known of this is the case for patients who have been born with their heart condition (congenital...

Detailed Description

Renal dysfunction is a recognised independent prognosticator in patients with chronic heart failure. Indeed it has been suggested that the clinical impact of renal dysfunction may be greater than that...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • The ability to give informed consent
  • Age \>18 years
  • Congenital heart disease being treated as an outpatient
  • Exclusion criteria:
  • Pregnancy
  • Renal failure requiring renal-replacement therapy
  • Known diabetes
  • Shellfish, iodine, or significant drug allergy (sub-study only).

Exclusion

    Key Trial Info

    Start Date :

    September 1 2008

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2010

    Estimated Enrollment :

    1200 Patients enrolled

    Trial Details

    Trial ID

    NCT00807274

    Start Date

    September 1 2008

    End Date

    December 1 2010

    Last Update

    September 25 2009

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Adult Congenital Heart Disease Unit, Royal Brompton Hospital

    London, London, United Kingdom, SW3 6NP